{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Ftoga-podcast.simplecast.com%2Fepisodes%2Ftoga-asm-2026-program-review-zMwG_huA","width":444,"version":"1.0","type":"rich","title":"TOGA ASM 2026: Program Review","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/37b381d6-a6e7-4025-a6ac-23a0ce7134b8/66f40245-26e0-477e-b45a-c3578a62f0a9/podcast_creative_4_people.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/8cf01a9d-e574-40a5-a8dc-8e6ee9e4d95d\" height=\"200\" width=\"100%\" title=\"TOGA ASM 2026: Program Review\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this episode of 'Conversations in Lung Cancer Research,' host A/Prof Surein Arulananda (Medical Oncologist, Monash Health) is joined by members of the Local Organising Committee to provide an exclusive preview of the 2026 TOGA Annual Scientific Meeting (ASM). The panel discusses the most anticipated sessions, emerging themes in thoracic oncology, and the evolving landscape of lung cancer care in Australia and New Zealand."}